Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Si-Miao-Yong-An Decoction ameliorates deep vein thrombosis by suppressing NAT10-mediated ac4C modification of HMOX1 mRNA.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Hydrogen-Bond-Directed Assembly of Polyanionic Cluster [Mo<sub>2</sub>O<sub>5</sub>(IO<sub>3</sub>)<sub>4</sub>]<sup>2-</sup> for Nonlinear Optical Crystal Design.

Inorganic chemistry·2026
Same author

PM<sub>2.5</sub>-bound organophosphate esters and childhood attention-deficit hyperactivity disorder symptoms: A population-based study from China.

Neurotoxicology·2026
Same author

Exposure to Per- and Polyfluoroalkyl Substances and the Risk of Sarcopenia: The Mediating Role of Serum Albumin.

Toxics·2026
Same author

Low-complexity mitigation of multipath interference in PAM-4 IM/DD systems via recursive filtering.

Optics express·2026
Same author

Authentication of Linderae Radix through plant metabolomics coupled with a machine learning-enhanced <i>in situ</i> hyperspectral imaging approach.

Journal of pharmaceutical analysis·2026

Related Experiment Video

Updated: May 26, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Engineered nanomedicine triggering ROS storms for enhanced cancer therapeutics.

Yuebing Hou1, Xiaoxuan Hou1, Yiyao Wang1

  • 1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.

Regenerative Biomaterials
|May 25, 2026
PubMed
Summary
This summary is machine-generated.

Engineered nanomaterials can trigger a "ROS storm" in tumors, causing severe oxidative damage for cancer treatment. This review explores strategies for enhancing reactive oxygen species (ROS) generation and their combination with other therapies.

Keywords:
ROS stormcancer treatmentnanomedicineoxidative stress

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Related Experiment Videos

Last Updated: May 26, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Area of Science:

  • Nanomedicine
  • Biochemistry
  • Oncology

Background:

  • Reactive oxygen species (ROS) are crucial for cellular signaling but cause damage when accumulated.
  • Excessive ROS can damage DNA, proteins, and lipids.
  • Nanotechnology offers strategies to induce a 'ROS storm' for tumor treatment.

Purpose of the Study:

  • To review engineered nanomaterial strategies for triggering ROS storms in tumors.
  • To discuss the mechanisms and effects of ROS storm therapy.
  • To explore the combination of ROS storm therapy with other treatments like immunotherapy.

Main Methods:

  • Review of existing literature on nanomaterials and ROS storm therapy.
  • Analysis of strategies to augment ROS generation (e.g., substrate supply, inhibiting antioxidants).
  • Examination of methods to enhance catalytic efficiency and species diversity.

Main Results:

  • Engineered nanomaterials can effectively induce ROS storms in tumor tissues.
  • Strategies include augmenting substrate supply, inhibiting antioxidant systems, and enhancing catalytic efficiency.
  • Combining ROS storm therapy with immunotherapy shows significant potential.

Conclusions:

  • ROS storm therapy using engineered nanomaterials is a promising approach for cancer treatment.
  • Further research is needed to address clinical application challenges.
  • This strategy holds potential for advancing cancer nanomedicine.